| Code | 1290E | ||||||||||
| MA number | 59/0182/22-S | ||||||||||
| Product Form: | tbl flm 63x267 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.06.2022 |
| Validity: | 29.06.2027 |
| Dokument: |
Pirfenidón_Kontrolný zoznam pre lekára.pdf
|
| SPC: |
SPC_Pirfenidone Teva 267 mg_ 801 mg tbl flm_06.2024.pdf
|
| PIL: |
PIL_Pirfenidone Teva 267 mg_ 801 mg tbl flm_06.2024.pdf
|
| Safety feature | Yes |
| Data update: | 01.07.2022 |
